Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer
Open Access
- 19 April 2021
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (4) , 316
Abstract
This paper investigates the expression of the CREB1 gene in ovarian cancer (OV) by deeply excavating the gene information in the multiple databases and the mechanism thereof. In short, we found that the expression of the CREB1 gene in ovarian cancer tissue was significantly higher than that of normal ovarian tissue. Kaplan–Meier survival analysis showed that the overall survival was significantly shorter in patients with high expression of the CREB1 gene than those in patients with low expression of the CREB1 gene, and the prognosis of patients with low expression of the CREB1 gene was better. The CREB1 gene may play a role in the occurrence and development of ovarian cancer by regulating the process of protein. Based on differentially expressed genes, 20 small-molecule drugs that potentially target CREB1 with abnormal expression in OV were obtained from the CMap database. Among these compounds, we found that naloxone has the greatest therapeutic value for OV. The high expression of the CREB1 gene may be an indicator of poor prognosis in ovarian cancer patients. Targeting CREB1 may be a potential tool for the diagnosis and treatment of OV.Keywords
This publication has 41 references indexed in Scilit:
- The Reactome pathway knowledgebaseNucleic Acids Research, 2013
- cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23aProceedings of the National Academy of Sciences, 2012
- Camp-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destructionBone, 2011
- Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IκB/NF-κB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathwayInternational Journal of Oncology, 2010
- CREB: A Key Regulator of Normal and Neoplastic HematopoiesisAdvances in Hematology, 2009
- Growth Suppression of Lung Cancer Cells by Targeting Cyclic AMP Response Element-Binding ProteinCancer Research, 2008
- cAMP response element-binding (CREB) signalling and ovarian surface epithelial cell survivalJournal of Endocrinology, 2006
- CREB Regulates AChE-R-Induced Proliferation of Human Glioblastoma CellsNeoplasia, 2004
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor FunctionThe American Journal of Pathology, 2003
- Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin geneNature, 1987